课题基金 / 基金详情

INTRACELLULAR CALCIUM STORE & SMOOTH MUSCLE CELL CA INDEPENDNT PHOSPHOLIPOASE A2

INTRACELLULAR CALCIUM STORE & SMOOTH MUSCLE CELL CA INDEPENDNT PHOSPHOLIPOASE A2
细胞内钙储存
批准号:
6118609
负责人:
Matthew J Wolf
金额:
$0.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 1999-07-31

项目摘要

项目成果

Matthew J Wolf的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Herein we present multiple lines of evidence which demonstrate that depletion of internal calcium stores is both necessary and sufficient for the activation of calcium-independent phospholipase A2 during arginine vasopressin (AVP)-mediated mobilization of arachidonic acid in A-10 smooth muscle cells. First, AVP-induced [3H]arachidonic acid release was independent of increases in cytosolic calcium yet was decreased by pharmacological inhibition of the release of calcium ion from internal stores. Second, thapsigargin induced the dramatic release of [2H]arachidonic acid from A-10 cells at a similar rate as the AVP-induced release of arachidonic acid, and the release of arachidonic acid by either AVP or thapsigargin was entirely inhibited by (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one (BEL). A23187 and thapsigargin also induce arachidonate release from pancreatic islet beta cells, as demonstrated by isotope dilution mass spectrometry, by a BEL-sensitive mechanism. Collectively, these results identify a novel paradigm which links alterations in calcium homeostasis to the calmodulin-mediated regulation of calcium-independent phospholipase A2 through the depletion of internal calcium stores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A CRISPR-based modular transgenic system to advance in vivo investigations of angiogenesis and fibrosis
  • 批准号:
    10408193
  • 项目类别:
  • 资助金额:
    $24.23万
  • 财政年份:
    2022
  • 负责人:
    Matthew J Wolf
  • 依托单位:
DYRK1a as a therapeutic target to treat myocardial infarction
  • 批准号:
    10458688
  • 项目类别:
  • 资助金额:
    $40.38万
  • 财政年份:
    2021
  • 负责人:
    Matthew J Wolf
  • 依托单位:
DYRK1a as a therapeutic target to treat myocardial infarction
  • 批准号:
    10274952
  • 项目类别:
  • 资助金额:
    $40.38万
  • 财政年份:
    2021
  • 负责人:
    Matthew J Wolf
  • 依托单位:
DYRK1a as a therapeutic target to treat myocardial infarction
  • 批准号:
    10670197
  • 项目类别:
  • 资助金额:
    $40.38万
  • 财政年份:
    2021
  • 负责人:
    Matthew J Wolf
  • 依托单位:
海外基金